Insights

Discover our latest thinking on patent and industry trends

Analog Devices buys Maxim

What does rhe Analog Devices acquisition of Maxim Integrated mean for the semiconductor industry? This Cipher report analyses the portfolio strength of both companies.

Diagnostics and Drug Development

Our report reveals the main companies influencing the diagnostics and drug development patent landscape. It also shows how AI is revolutionising this space.

Due Diligence: don’t make the easy things hard

Advances in automated approaches to due diligence increase efficiency and reduce transaction costs – making the easy things, easy.

Next Generation Solar

What are the emerging technologies for Solar and who are the key technology players for solar and energy Transition?

SPIF Press release

Launching SPIF, bringing transparency to patent data and making patent management and transfer more efficient.

Next Generation Batteries

Our report looks at the inventions and innovations being made in critical technologies powering the energy transition, and their associated patents.

Cipher Benchmarking Study

Hear from Google, ARM, Facebook and many other large patent owning organisations in the full Cipher report. Take a look at what the world’s patent owning organisations are saying about benchmarking and its importance in patenting strategy.

Benchmarking your patent portfolio – the key to your patenting strategy

WEBINAR
The Key Findings from the Benchmarking your Patent Portfolio Study are out! Catch up on the recording as we delve into each key finding and hear from industry experts at Facebook and Paragraf.

Benchmarking Patent Portfolios Report – Key Findings

Hear from leading patent owning organisations on the importance of benchmarking your patent portfolio in our Benchmarking Study.

Mintel Cipher Press release

Get the consumer trends behind the patent data with an exclusive offer for Mintel and Cipher customers

Inbound Patent Assertion: how to respond to the challenge

Patent assertion is set to increase due to the economic downturn – are you in a position to respond efficiently and effectively?

CRISPR Nobel Prize

Controversy around the Nobel Prize awarded to the gene editing tool, CRISPR, continues. But who controls the patent assets?

Loading...

End of content

No more pages to load

Improve your patent strategy now

Speak to our team today.

Request a demo

Arrange a callback

  • Please note we will do our best to call you at the time you selected but due to different time zones this may not always be possible. We are based in London, UK.